Published December 30, 2023 | Version http://impactfactor.org/PDF/IJTPR/13/IJTPR,Vol13,Issue12,Article60.pdf
Journal article Open

A Study Assessing Histopathological Features and Classify Tumors of Prostate as Per Recommendations of WHO: An Observational Study

  • 1. Assistant Professor, Department of Pathology, Lord Buddha Koshi Medical College and Hospital, Saharsa, Bihar, India
  • 2. Associate Professor, Department of Pathology, Shree Narayan Medical Institute and Hospital, Saharsa, Bihar, India

Description

Aim: The aim of the present study was to assess the incidence, age distribution, gross and histopathological features of lesions of prostate and to classify tumours of prostate as per recommendations of WHO. Methods: An observational study conducted in the Department of Pathology for the period of 2 years and 100 patients were included in the study. Results: Most prostatic samples were benign (90%), whereas 9% were cancerous. Our analysis found 1 case of Prostatic Intra-epithelial Neoplasia (PIN). BPH was most common in those aged 61–70, with 39 cases (39%). Six BPH patients (6%) had chronic prostatitis and two (2%) had acute prostatitis. Three BPH patients (3%) had basal cell hyperplasia and one had squamous metaplasia. We recorded 10 prostate cancer cases utilizing modified Gleason Grading. Gleason’s score 7 was the most common in 3 of 10 adenocarcinomas. Conclusion: Adenocarcinoma was most common in those aged 61–70. All prostate biopsies must be examined for premalignant abnormalities, proliferative activity, and inflammation. Successful prostate cancer therapy depends on histology detection and classification.

Abstract (English)

Aim: The aim of the present study was to assess the incidence, age distribution, gross and histopathological features of lesions of prostate and to classify tumours of prostate as per recommendations of WHO. Methods: An observational study conducted in the Department of Pathology for the period of 2 years and 100 patients were included in the study. Results: Most prostatic samples were benign (90%), whereas 9% were cancerous. Our analysis found 1 case of Prostatic Intra-epithelial Neoplasia (PIN). BPH was most common in those aged 61–70, with 39 cases (39%). Six BPH patients (6%) had chronic prostatitis and two (2%) had acute prostatitis. Three BPH patients (3%) had basal cell hyperplasia and one had squamous metaplasia. We recorded 10 prostate cancer cases utilizing modified Gleason Grading. Gleason’s score 7 was the most common in 3 of 10 adenocarcinomas. Conclusion: Adenocarcinoma was most common in those aged 61–70. All prostate biopsies must be examined for premalignant abnormalities, proliferative activity, and inflammation. Successful prostate cancer therapy depends on histology detection and classification.

Files

IJTPR,Vol13,Issue12,Article60.pdf

Files (314.6 kB)

Name Size Download all
md5:3815407db7704b4ecbd5c1c264e40be4
314.6 kB Preview Download

Additional details

Dates

Accepted
2023-07-23

References

  • 1. Rosai J. Rosai and Ackerman's surgical pathology e-book. Elsevier Health Sciences; 20 11 Jun 20. 2. Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease. InRobbins pathologic basis of disease 1999 (pp. xv-1425). 3. Sumaya, Das M, Nagesha KR. Spectrum of histopathological lesions of prostate in a tertiary care center. Int J Clin DiagnPa thol. 2020; 3(1):110-3. 4. Yelave R, Shahnaaz Z, Pawar V. Histopathological study of prostatic lesions in a tertiary care hospital. J Diagn Pathol Oncol. 2020; 5(2) :200-7 5. Shah R, Karki S, Shah N, Dhakal S, Singh SK, Chaudhari RK. Histopathological Study of Prostatic Diseases in BPKIHS, Nepal: A Hospital Based Study.6. Kumar V, Abbas AK, Fausto N, editors. Prostate. In: Robbins Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders Company; 199 9. 7. Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5α– reductase inhibition in human benign prostatic hyperplasia. European urology. 2000 Mar 17; 37(4):367-80. 8. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer: epidemiologic and clinical features. The Journal of urology. 1993 Sep;150 (3):797-802. 9. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer. 1960 Jul;13(4):739-44. 10. Carter HB, Piantadosi S, Isaacs JT. Clinical evidence for and implications of the multistep development of prostate cancer. The Journal of urology. 1990 Apr 1;143(4):742-6. 11. Rosai J. Male reproductive system. In: Rosai & Ackerman's. Surgical Pathology. 9th ed. Vol.1, Missouri: Mosby; 2004:1361-1412. 12. Bostwick DG, Amin MB. Male reproductive system. In: Damjanov I, Linder J, editors. Anderson's pathology. Vol.1, 10th Ed., Missouri: Mosby; 1996.p.2197-2222. 13. Matapurkar BG, Taneja OP. Incidence of carcinoma prostate. Ind. J of Cancer, 1969, 172- 182. 14. Sharma GC, Mathur SC, Sharma ML. Occult carcinoma in benign hypertrophy of prostate (Clinicopathological study of 100 cases). Ind. J Surg., 1972, 152-155. 15. Neha Angurana. Pattern of prostrate diseases-a histopathological study in jammu, international journal of basic and applied medical sciences ISSN: 2277-2103 (online) 16. Mostofi FK. Benign hyperplasia of the prostate gland. In Campbell MF, Harrison JH eds. Urology, 3rd ed. Philadelphia: WB Saunders, 1970, 10-65. 17. Peterson RO, Sesterhenn IA, Davis CJ. Editors. Prostate. In: Urologic Pathology. Lippincott Williams and Wilkins, 2009, 451-559.